Relating to training on the uses and indications of certain drugs for pregnant women.

HB 5442 requires hospitals and healthcare providers in West Virginia to complete training on the uses and risks of progesterone and mifepristone for pregnant women, specifically focusing on medication abortion (referred to as "chemical abortion" in the bill). The training covers how progesterone can counteract mifepristone and how to identify/treat complications from medication abortion, developed by the Office of Maternal, Child and Family Health. Hospitals providing gynecologic, obstetric, or emergency care must ensure their licensed staff complete this training, with restrictions preventing contracts with organizations defined as part of the "abortion industry." The bill does not change abortion access but mandates standardized education for healthcare providers.